Insider trade

Director sold ~$782K of PTCT shares in the open market

Traded Sep 30, 2026 · Filed Oct 3, 2026

Why it stands out

A PTC Therapeutics director sold $782K of PTC Therapeutics shares. The filing says it was made under a pre-arranged trading plan.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Director$500K–$1MPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$781,920

Shares × reported transaction price

Timing vs results

62 days after results of Jul 30, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 9, 2026

Planned, from payFiled yesterday

Planned, from payFiled 2d ago

Filed 4d ago

Traded Sep 30 · filed 3 days later

Derivative exercise or conversion — not an open-market buy.